At a glance
ClinicalIndex Comparison RecordN/ACompleted· 818 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Adolescent Master Protocol for Participants 18 Years of Age and Older (AMP Up)
In Brief
An observational study for HIV/AIDS. Completed, enrolled 818 participants across 14 sites in 2 countries.
Detailed Summary
This is a prospective cohort study designed to define the impact of HIV infection and antiretroviral therapy (ART) on young adults with perinatal HIV infection (YAPHIV) as they transition into adulthood. A group of of perinatally exposed but uninfected young adults from a similar sociodemographic background and age distribution will be enrolled for comparison.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsHIV/AIDS
CountriesPuerto Rico, United States
CollaboratorsEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Institute on Drug Abuse (NIDA), National Institute of Allergy and Infectious Diseases (NIAID), NIH Office of AIDS Research (OAR), National Institute of Mental Health (NIMH), National Institute of Neurological Disorders and Stroke (NINDS), National Institute on Deafness and Other Communication Disorders (NIDCD), National Heart, Lung, and Blood Institute (NHLBI), National Institute of Dental and Craniofacial Research (NIDCR), National Institute on Alcohol Abuse and Alcoholism (NIAAA), Tulane University School of Medicine
Timeline
N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
Enrollment StartApr 2014
First PostedApr 2014
Primary CompletionMay 2025
TodayJul 2026
First PostedApr 22, 2014
Enrollment StartApr 1, 2014
Primary CompletionMay 31, 2025
TodayJul 2, 2026
Enrollment to primary: 11.2 yearsPosted 12.2 years ago